Check out our projects and collaborations

Cherry Biotech is rooted in academics labs. Our first CherryTemp technology has been originally developped at the Institut Curie and the ENS Paris during CEO Jeremy Cramer’s PhD work.

We naturally follow on building tight relationships with academic labs as we know that basic science is the breeding ground of innovation. Our challenge is to transfer ideas into technologies and make them available for the scientific community. Our partners are precious advisors for our developments.

Our objective is to build the “Organ-on-a-chip tree of knowledge”. We want to build a strong multidisciplinary network and realize the first Human-on-a-chip to revolutionize diagnosis and drug development.


DeLIVER is a European consortium where PhD students will be trained to super-resolution (nanoscopy) with a unique goal of live imaging nanopores of a Liver-on-a-chip. Indeed, going through the optical diffraction limit set by the Abbe law is key to observe nanoscaled structures like the nanopores of endothelial barriers. To achieve this goal, cutting-edge techniques combining SR-SIM, high speed and high resolution nanoscopy and microfluidic devices will allow live cell imaging of 3D cell culture. LEARN MORE.

EUROSTARS | i-Bracelet

Pre-eclampsia is a pathology affecting 10% of pregnant women. The main symptom is high blood pressure. The i-bracelet project aims at developing a connected wristband for the detection of pre-eclampsia, by continuously measuring the blood pressure, thanks to a microfluidic based sensor. The i-bracelet project addresses two challenges : to build a highly sensitive sensor and to develop a reliable algorithm for the symptom detection. Cherry Biotech is the project coordinator and collaborates with 4 partners in France and Romania.

GATEONE | Cell µBioreactor

Teesside University and Cherry Biotech have been selected to work on a miniaturized microbioreactor. This device will allow long-term culture and monitoring of liveing cells. In addition to constant perfusion and cell monitoring (pH, density…), this project aims at sensing metabolites in a user-friendly microbioreactor.

This project is a perfect example of Cherry’s focus at working in tightrelationship with end users on specific lab challenges.

BPI france i-LAB | Homo chipien

Cherry Biotech has been awarded by the French Ministry of Research through the BPIfrance i-LAB program for a breakthrough Human-on-a-Chip research program. Through the development of interconnected Organs-on-chips, our R&D team aims at developing the first so-called Human-on-a-Chip for preclinical and clinical assays. Such revolutionnary microfluidic in vitro techniques offers an alternative to animal drug testing and increase the number and quality of drugs for people. LEARN MORE.


DivIDE is a European consortium where PhD students are trained to cell cycle, cell division and cutting-edge techniques ranging from cell biology to biochemistry. Students are hosted in top-level groups and institutes (London CRIK, Institut Curie Paris, CRG Barcelona, MPI Dortmund, Dresden, Heidelberg). The project aims to investigate the mechanisms and principles of cell division and to reproduce them in vitro with synthetic approaches. LEARN MORE.


Cherry360 comes from CEO Jeremy Cramer and CNRS Research Director Damien Coudreuse meeting in 2013. Both convinced that the technology developed by Jeremy was valuable for biological labs, they wrote a co-development project which had been supported by local actors until 2016 (Région Bretagne, ID2Santé). The project aimed at developing a microfluidic platform for the environmental control and high resolution imaging of yeast cells. LEARN MORE.


SpOC project comes from a close collaboration between Cherry Biotech and the Institut de Génétique De Rennes (IGDR). Since both partners are convinced that 3D cell culture is the future of cell culture they naturally decided to merge their expertise within a common project. The project aimed at developing a microfluidic device allowing the long-term culture and live imaging of spheroids. It opens the perspectives of personalized medicine and more efficient drug development. LEARN MORE

H2020 program | SeCtOR ENABleRs

The main challenge of SeCtOR ENABlerRs is to develop, validate and industrialize a multipurpose and platform to unleash the power of microfluidics. This H2020-MSCA-Individual Fellowhip project aims to provide the scientific community of a userfriendly and tailorable platform able to replicate the complexity of tissue and organs. Essential for the whole project is the possibility to rapidly change the temperature of the chip; a task in which the CherryTemp system has no eguals. LEARN MORE.

H2020 program | BrainChip

When studying how neurological conditions impact connected regions of the brain, it is very important to implement different brain regions into more realistic in vitro models. We will work on the development of an automated system based in the use of microfluidics, extracellular matrixes and perfused three-dimensional multicellular environments to achieve a better reproduction of in vivo models while improving intercellular connectivity, cellular survival, interconnected cellular niches separation and neuronal differentiation in vitro. LEARN MORE.


IMAGINe will develop a device for long-term imaging of Organ-on-a-Chip applications. IMAGINe aims at creating a skin-on-a-chip model. This enabling technology controls the environment (e.g. temperature, fluid flow) of Organ-on-a-Chip cultures to keep these viable during imaging. The IMAGINe device uniquely enables the long-term monitoring of cellular processes in the Organ-on-a-Chip. This will be validated using a human skin-on-chip and a metastatic melanoma-on-chip model, in combination with novel cell-based therapeutics to inhibit metastasis.


CISTEM aims at developing a Heart-On-a-chip based on induced pluripotent Stem cell Technology for personalized Medicine. By promoting international staff exchange, CISTEM will provide a novel miniaturized platform for investigation of muscular rare diseases (Duchenne Muscular Dystrophy) able to address the burning issues in precision medicine today. CISTEM will bring together and synergistically several highly promising research directions which are too often investigated separately at the academic level but also at the industrial one.

This is a unique website which will require a more modern browser to work! Please upgrade today!